# Immunovant, Inc.: Form 4, filed Jan 15, 2025

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: 4
- Filed: 2025-01-15
- Accepted by EDGAR: Jan 15, 2025, 16:36 ET
- Period: 2025-01-13
- Accession: 0001140361-25-001188
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000114036125001188/xslF345X05/form4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000114036125001188/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000114036125001188/xslF345X05/form4.xml

Filed Jan 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-001188. Last ingested by Listed: Nov 13, 2026, 16:26 ET. No prices; not investment advice.
